In addition, GLP-1R agonist exendin-4 has been shown to increase antioxidants (SOD-1 and glutathione peroxidase) to improve myocardial oxidative stress and ameliorates cardiac dysfunction in type 2 diabetes (48). Here, SOD1 is linked to type 2 diabetes mellitus.